What are the top digital health startups by total funding raised?

Top startups in the Digital Health market ranked by total funding raised

Here is an updated table that ranks the top startups in the Digital Health market based on the total amount of funding they have raised to date.

The table also includes the total number of funding rounds, the date and size of the latest round, the financing type (e.g. Series A, equity financing), key investors, the startup’s current status (active, IPO, acquired, or shut down), and a confidence score based on the data collected (we excluded startups with very low data confidence, to make sure everything is reliable).

If you need to dig deeper and get more detailed data, please check our report covering the Digital Health market.

The most funded digital health startups are still led by older telehealth and virtual-care companies, but healthcare AI is catching them much faster than previous generations did.

Amwell ranks first in our dataset with $1.7 billion raised, followed by Ro at $1.0 billion, Lyra Health at $890 million and Hinge Health at $826 million. Abridge is already fifth at $758 million. Aledade and Innovaccer follow with $678 million and $653 million.

That top group is much more diverse than the usual image of digital health. Amwell and Ro grew out of virtual care. Lyra focuses on mental health. Hinge built digital musculoskeletal care. Abridge automates clinical documentation. Aledade helps primary-care practices move toward value-based care, while Innovaccer sells healthcare data and AI software.

The top 10 companies alone have raised roughly $7.9 billion in our dataset, around 35% of all the funding represented by the 100 companies we ranked.

Rank	Digital health company	Total raised	Main business
1	Amwell	$1.7B	Telehealth
2	Ro	$1.0B	Virtual healthcare
3	Lyra Health	$890M	Mental health
4	Hinge Health	$826M	Musculoskeletal care
5	Abridge	$758M	Clinical AI
6	Aledade	$678M	Value-based care
7	Innovaccer	$653M	Healthcare data and AI
8	Spring Health	$467M	Mental health
9	Biofourmis	$464M	Remote monitoring
10	Cerebral	$462M	Mental health
11	Omada Health	$449M	Chronic care
12	Commure	$436M	Healthcare operations AI

Is Amwell really the best-funded digital health company?

Amwell has raised the most cumulative capital in our ranking, although its $1.7 billion total says more about its long financing history than about where investors are placing the biggest bets today.

Amwell's total includes the $822 million associated with its 2020 IPO. That puts the company in a different position from private companies such as Ro or Abridge, which built most of their totals through venture and growth-equity rounds.

The distinction becomes useful when comparing fundraising momentum. Amwell's biggest financing event happened years ago. Abridge, Talkiatry, Grow Therapy, Midi Health and Cadence have added large amounts of capital far more recently.

Amwell therefore deserves the top position under a cumulative-funding definition. If the question is where new money is flowing right now, the fastest-rising companies further down the ranking are more revealing.

How much funding have the top 100 digital health companies raised?

The 100 digital health companies in our dataset have raised at least about $22.7 billion in cumulative funding.

We calculated that amount from the company totals in the ranking. The real figure is somewhat higher because several entries carry a "+", some financing amounts were never disclosed publicly, and older records can be incomplete.

The concentration becomes obvious very quickly. The first five companies account for roughly $5.2 billion. The top 20 account for around $11.8 billion, so about one-fifth of the companies hold more than half of the funding represented in the table.

By company number 50, cumulative funding already reaches roughly $18.5 billion. More than four-fifths of the capital therefore sits in the upper half of the ranking.

That distribution tells us more than the $22.7 billion headline. Digital health has produced a large population of venture-backed companies, yet a relatively small group absorbed a huge share of the available money.

How concentrated is digital health startup funding?

Digital health funding is highly concentrated: roughly 35% of the capital in our dataset belongs to the top 10 companies, about 52% to the top 20 and around 82% to the top 50.

Recent market data points in the same direction. Rock Health counted $14.2 billion of U.S. digital health venture funding across 482 deals in 2025. Funding increased 35% from 2024 even though the number of deals fell from 509.

The latest quarterly data makes the concentration even clearer. Rock Health recorded roughly $4 billion across 110 U.S. digital health deals in the first quarter of 2026, with just 12 mega-rounds taking 59% of all the money raised.

So the concentration visible in our historical ranking is still happening. Bigger pools of capital are being placed behind a narrower group of companies.

Group in our ranking	Approx. cumulative funding	Share of top-100 funding
Top 5	$5.2B	23%
Top 10	$7.9B	35%
Top 20	$11.8B	52%
Top 30	$15.1B	66%
Top 40	$17.1B	75%
Top 50	$18.5B	82%
Top 100	$22.7B+	100%

Is digital health funding actually back?

Digital health funding has clearly recovered from its post-boom slump, although investors are being much more selective than they were during the 2020-2021 rush.

Rock Health counted $14.2 billion of U.S. digital health venture investment in 2025, up from $10.5 billion in 2024 and the strongest annual total since 2022.

The interesting part is what happened to deal count. Funding jumped 35%, while the number of financings actually fell by about 5%. Average deal size increased from $20.7 million in 2024 to $29.3 million in 2025.

The trend continued into 2026. The latest Rock Health quarterly data shows around $4 billion invested across 110 deals, with most of that money captured by a small group of mega-rounds.

That's a real recovery in dollars. For a startup outside the small group attracting big checks, fundraising can still be difficult.

Are $100 million digital health funding rounds common again?

Nine-figure digital health rounds have returned in force at the top of the market, even though they remain exceptional for the average startup.

Rock Health counted 26 U.S. digital health rounds of at least $100 million in 2025, up from 18 in 2024. Those mega-rounds represented 42% of all U.S. sector funding during the year.

The concentration became even stronger recently. Twelve mega-rounds represented 59% of U.S. digital health funding in the first quarter of 2026.

Our dataset shows the same pattern at company level. Talkiatry raised $210 million, Grow Therapy $150 million, Solace Health $130 million, and both Midi Health and Cadence raised $100 million. Pomelo Care came close with a $92 million Series C.

Nine-figure financing is therefore becoming familiar again when we look at digital health headlines. It is still concentrated among companies investors already see as potential category leaders.

Which digital health startups have raised the biggest recent rounds?

Some of the biggest recent digital health rounds went to Talkiatry, Grow Therapy, Solace Health, Midi Health, Cadence and Pomelo Care, with healthcare AI generating several additional large financings.

Talkiatry raised $210 million in a Series D. Grow Therapy followed with $150 million. Solace Health secured $130 million. Midi Health and Cadence each added $100 million, while Pomelo Care raised $92 million at a $1.7 billion valuation.

Abridge had already reset expectations for healthcare AI funding with a $250 million Series D followed only four months later by a $300 million Series E in 2025. Ambience Healthcare raised $243 million in its Series C.

There are fresh companies outside our supplied ranking that also matter. Heidi recently raised a $100 million Series C at a $900 million valuation. The company announced another $240 million through General Catalyst's Customer Value Fund, although we keep that growth facility separate from the conventional equity round when comparing cumulative equity funding.

A headline can therefore describe several hundred million dollars of financing even when only part of that amount represents new equity invested directly into the company.

Company	Recent round	Amount	Main area
Abridge	Series E	$300M	Clinical AI
Ambience Healthcare	Series C	$243M	Clinical AI
Talkiatry	Series D	$210M	Psychiatry
Grow Therapy	Series D	$150M	Mental health
Solace Health	Series C	$130M	Patient advocacy
Midi Health	Series D	$100M	Women's health
Cadence	Series C	$100M	Chronic care
Heidi	Series C	$100M	Clinical AI
Pomelo Care	Series C	$92M	Women's and children's care

Is AI taking over digital health funding?

AI has become the biggest force in digital health venture funding, especially in clinical and administrative workflows.

Rock Health found that AI-enabled companies captured 54% of U.S. digital health funding in 2025, up from 37% the year before. Around half of all deals involved companies identified as AI-enabled.

Investors also paid a clear premium. Rock Health found that AI-enabled digital health companies raised rounds about 19% larger on average than companies without an explicit AI focus. At Series C, the gap reached 61%.

The companies climbing our ranking explain why. Abridge automates clinical documentation and related workflows. Ambience works across documentation, coding and clinical administration. Commure is building healthcare operations software. Suki focuses on clinician voice workflows. CodaMetrix automates medical coding, while AKASA focuses on revenue-cycle work.

A lot of healthcare AI funding is going toward expensive work already performed inside hospitals and medical practices. The financial case is easier to make when the software replaces or speeds up something organizations already spend heavily on.

Why has Abridge raised so much money so quickly?

Abridge has raised $758 million because clinical documentation AI moved from an interesting physician tool to a major health-system software category in a very short period.

The fundraising speed is unusually aggressive. Abridge raised a $150 million Series C in 2024, followed by a $250 million Series D in early 2025 and a $300 million Series E four months later.

Those three rounds alone represent about $700 million, or more than 90% of the cumulative total in our dataset.

The operational growth moved quickly as well. When Abridge announced its Series D, it said the platform had been deployed across more than 100 health systems, including enterprise implementations at Mayo Clinic, Johns Hopkins, Duke Health and UNC Health. By the Series E announcement, Abridge said it was working with more than 150 enterprise health systems.

Few companies in this ranking accumulated so much of their lifetime funding over such a short window. Abridge is one of the clearest examples of how healthcare AI has changed the fundraising hierarchy.

Which healthcare AI startups have raised the most funding?

Abridge is the best-funded healthcare AI company in our dataset at $758 million, while Commure and Ambience Healthcare form the next major group.

Commure sits at $436 million using the funding methodology in our supplied ranking. Ambience has crossed $300 million under widely reported cumulative estimates after raising a $243 million Series C.

Further down, Suki has raised $165 million, CodaMetrix $107 million, AKASA $85 million and Fabric $80 million.

These companies work on different problems, but most sell directly into healthcare organizations. Their products automate documentation, coding, revenue-cycle work, patient intake and clinical operations.

Heidi is also moving quickly. Its new $100 million Series C brings another large clinical-AI company much closer to the established group, while the additional $240 million growth facility gives it substantial capacity to fund expansion without treating the whole package as conventional equity for ranking purposes.

Healthcare AI company	Funding represented in our ranking	Main use case
Abridge	$758M	Clinical documentation
Commure	$436M	Healthcare operations
Ambience Healthcare	$343M	Documentation and coding
Suki	$165M	Clinical voice assistant
CodaMetrix	$107M	Medical coding
AKASA	$85M	Revenue-cycle automation
Fabric	$80M	Healthcare workflow automation

Which mental health startups have raised the most money?

Lyra Health remains the funding leader in digital mental health at $890 million, while Talkiatry, Grow Therapy and Headway are forming a fast-growing second generation of heavily funded companies.

Spring Health follows Lyra at $467 million, with Cerebral close behind at $462 million. Talkiatry now sits at $388 million in our dataset after its $210 million Series D. Grow Therapy has reached at least $328 million, and Headway stands at $327 million.

Across 11 clearly mental-health-focused companies in the top 100, we count roughly $3.8 billion of cumulative funding. That conservative group includes Lyra, Spring Health, Cerebral, Talkiatry, Grow Therapy, Headway, Alma, Quartet Health, Brightline, SonderMind and Brightside Health.

The newer companies are also built differently. Talkiatry says it now employs more than 800 full-time psychiatrists. Grow Therapy increasingly works with insurers, employers and health systems. Headway built its business around helping mental-health providers participate in insurance networks.

Mental health remains one of digital health's biggest funding categories. Lately, more of the money has been moving toward companies that fit naturally inside reimbursement and provider networks.

Are women's health startups finally raising serious money?

Women's digital health has become a multibillion-dollar funding category, with several companies now raising rounds that would have looked unusually large for the sector a few years ago.

A conservative group in our dataset, including Maven Clinic, Flo Health, Midi Health, Pomelo Care, Willow, Advantia Health, Kindbody, Tia, Diana Health, Nurx, Clue and Oula, has raised more than $2 billion altogether.

Maven Clinic leads at $415 million. Flo Health has raised roughly $271 million, including a $200 million-plus Series C. Midi Health reached $249 million after its recent $100 million Series D. Pomelo Care has raised around $171 million following a $92 million Series C that valued the company at $1.7 billion.

The category has also widened. Funding now covers maternity, fertility, menopause, reproductive care, longitudinal women's care and children's health.

Midi is expanding beyond menopause and midlife care toward a broader women's-health platform. Pomelo has moved beyond maternity into women's and children's healthcare. Investors are increasingly financing companies that can follow patients across several stages of care.

Is traditional telehealth still attracting big funding rounds?

Virtual care still attracts capital, but simply offering a video visit is no longer enough to make a digital health company stand out.

The older ranking is full of companies built around virtual access. Amwell raised $1.7 billion. Ro raised $1 billion. Doctor On Demand raised $236 million, 98point6 raised $266 million, and Current Health raised $66 million before being acquired.

Today's better-funded virtual-care companies tend to add a specialized clinical model, reimbursement infrastructure or proprietary technology. Talkiatry combines virtual psychiatry with insurer relationships and employed psychiatrists. Midi focuses on women's care. Pomelo targets women's and children's health. Cadence combines monitoring with longitudinal chronic care.

TytoCare offers another example. The company recently raised more than $25 million while repositioning around an AI-first clinical platform built on remote physical examinations and FDA-cleared technology.

Virtual delivery has become part of the infrastructure of healthcare. What a company builds around that delivery channel now matters much more to investors.

Which chronic-care digital health startups have raised the most funding?

Hinge Health leads chronic and specialty digital care with $826 million raised, followed by Omada Health, Virta Health, Sword Health and Twin Health.

Omada raised $449 million before going public. Virta Health sits at $403 million, Sword Health at $365 million and Twin Health at more than $345 million in our dataset.

Cadence is moving up quickly after adding a $100 million Series C to reach more than $240 million in cumulative funding. Vida Health has raised $211 million, while FIRE1 and Lark are both around the $200 million mark.

These companies sit inside very large areas of healthcare spending: musculoskeletal conditions, diabetes, cardiovascular disease and metabolic health. Many also combine software with clinicians, devices or continuous monitoring, so the business can require far more capital than a conventional SaaS company.

Investors have continued funding the category because chronic conditions generate recurring healthcare costs over many years. A company that measurably changes those costs can become valuable to insurers, employers and health systems.

Are consumer health apps losing the funding race?

Consumer-first digital health companies are losing ground relative to enterprise and reimbursed-care businesses, although a few large brands still prove that consumer models can work at scale.

Flo Health is one of the strongest exceptions. Its $200 million-plus Series C pushed cumulative funding to roughly $271 million and showed that a consumer women's-health app with very large reach can still raise institutional-scale capital.

Hims & Hers offers another useful example. The company raised only about $197 million privately before becoming public, yet it developed a much larger consumer healthcare business afterward.

The faster-climbing private companies today generally have money coming from healthcare organizations or insurance flows. Abridge sells into health systems. Talkiatry and Grow Therapy work deeply with insurers. Cadence partners with health systems. Midi and Pomelo are building relationships with payers and employers.

Consumer digital health can still produce major companies. The fundraising bar is simply higher when the customer pays directly and switching costs are low.

What types of digital health startups are getting the most money now?

Healthcare AI, insured specialty care, women's health and chronic-care platforms are pulling in many of the biggest digital health checks these days.

Clinical and administrative AI is the clearest example. Abridge, Commure and Ambience alone represent well over $1 billion of funding in our dataset.

Mental-health companies tied into insurance networks have also become major fundraising stories. Talkiatry, Grow Therapy and Headway together account for more than $1 billion. Women's-health companies such as Maven, Midi, Flo and Pomelo have built another substantial pool of venture capital.

Chronic-care companies remain heavily funded as well. Hinge, Omada, Virta, Sword, Twin Health and Cadence together represent billions of dollars.

The pattern is pretty clear: investors increasingly favor digital-health companies connected to spending that already exists inside the healthcare system. Hospitals, insurers, employers and reimbursed clinical services offer much deeper revenue pools than most standalone wellness subscriptions.

Who are the biggest investors in digital health startups?

General Catalyst and Andreessen Horowitz are two of the most active and influential digital health investors, and both repeatedly appear behind companies near the top of our ranking.

General Catalyst appears across companies such as Commure, Maven Clinic, Sword Health, Cadence, SonderMind, Memora Health and Fabric. Andreessen Horowitz has backed companies including Talkiatry, Ambience Healthcare, Headway, Cedar, Pomelo Care, AKASA and Memora Health.

Galen Growth counted General Catalyst in 36 digital health deals during 2025 and Andreessen Horowitz in 20. Khosla Ventures was another highly active investor.

Their involvement also tends to coincide with larger financings. Rock Health found that rounds involving either General Catalyst or Andreessen Horowitz carried clear premiums across funding stages in 2025. At Series A, those rounds averaged roughly $24.1 million compared with $18.9 million for other deals. At Series D and beyond, the gap was around $265.7 million versus $172 million.

Part of that difference comes from selection: giant funds naturally chase companies already showing strong growth. Their ability to keep financing the same company through several stages still gives portfolio companies a real advantage when rounds start reaching nine figures.

Are Hinge Health and Omada Health proof that digital health IPOs are back?

Hinge Health and Omada Health proved that strong digital health companies can go public again, although the IPO window remains narrow.

Hinge Health completed its IPO in 2025 at $32 per share. SEC filings show the company received roughly $255.7 million in proceeds after underwriting discounts and commissions, before certain offering expenses.

Omada Health followed with an IPO at $19 per share. The company sold just over nine million shares after the underwriters exercised their option and received around $151.6 million in net proceeds.

Those listings were important after several quiet years for digital health IPOs. Rock Health's latest market review still describes the public exit window as narrow, with other potential candidates waiting.

For private companies in our ranking, Hinge and Omada show that an IPO is possible again. They also show the standard investors now expect: meaningful scale, a defined market and much more financial discipline than companies needed during the last boom.

Is digital health consolidation speeding up?

Digital health consolidation accelerated sharply in 2025, with large platforms buying smaller companies at the same time that venture capital became more concentrated.

Rock Health counted 195 digital health M&A transactions in 2025, up 61% from the previous year. Digital health companies themselves were responsible for 66% of those acquisitions.

Our dataset shows how much consolidation has already happened. Biofourmis, Doctor On Demand, 98point6, Alma, Quartet Health, Kyruus, Augmedix, Athelas, Nurx, Memora Health, Current Health, DrChrono, Lumeon and Wellframe are all marked as acquired.

Several of these companies raised well above $100 million before being bought. Biofourmis reached $464 million in our dataset, while 98point6 raised $266 million and Doctor On Demand $236 million.

Large fundraising totals therefore do not automatically lead to an IPO or an independent long-term company. In digital health, acquisition has become a common route for combining software, clinical teams, customers and distribution under larger platforms.

Which digital health startups are climbing the funding ranking fastest?

Abridge, Talkiatry, Grow Therapy, Midi Health, Pomelo Care and Cadence are among the fastest climbers because a single recent round added a huge percentage to their lifetime funding.

Abridge is the extreme case. Its Series C, D and E contributed about $700 million combined, representing more than 90% of the $758 million total in our ranking.

Talkiatry's $210 million Series D represents more than half of its current $388 million total. Grow Therapy's $150 million Series D accounts for almost half of its $328 million-plus cumulative funding.

Midi added $100 million to reach roughly $249 million. Cadence added another $100 million to pass $240 million. Pomelo Care's $92 million Series C pushed it to roughly $171 million.

A company sitting far below the leaders can now jump dozens of positions with one late-stage round. The ranking can move surprisingly fast.

Are the old digital health leaders being replaced by healthcare AI startups?

Healthcare AI startups are catching the older digital health leaders very quickly, although the biggest historical funding totals still belong largely to companies built during earlier waves.

Amwell, Ro, Lyra Health, Hinge Health, Aledade, Spring Health, Cerebral and Omada built large capital bases over many years. Several required seven, eight or more financing rounds to get there.

The newer group can move much faster. Abridge reached $758 million after a compressed sequence of huge rounds. Ambience raised $243 million in a single Series C. Heidi has now added a $100 million Series C while expanding well beyond basic note generation.

Their products also target a different part of healthcare. Earlier digital-health giants often focused on giving patients remote access to clinicians or managing specific conditions. The newest AI companies increasingly sell directly into the daily work of doctors, coders and hospital administrators.

The older leaders still dominate much of the cumulative ranking today. But healthcare AI companies can now accumulate capital at a speed that would have been unusual even during digital health's previous funding boom.

What does the digital health funding ranking tell us about the market today?

The digital health market is well funded again, but the strongest companies are taking an unusually large share of the money.

Our top 100 represent at least $22.7 billion of cumulative funding, and the top 20 already account for more than half of that amount. Current market data shows the same concentration: annual U.S. funding jumped 35% in 2025 even as deal count fell, while 12 mega-rounds captured 59% of the money invested in the latest reported quarter.

Healthcare AI is driving much of the change. AI-enabled companies captured 54% of U.S. digital health investment in 2025, and companies such as Abridge and Ambience have raised hundreds of millions within very short periods.

Specialized care remains powerful too. Mental-health companies in our ranking represent roughly $3.8 billion of cumulative funding, while a conservative group of women's-health companies has passed $2 billion. Chronic-care leaders such as Hinge Health, Omada, Virta, Sword and Twin Health add several billion more.

The clearest shift is in what investors reward. Large checks increasingly go to companies tied directly into hospital workflows, insurance reimbursement, healthcare operations or high-cost clinical conditions.

The funding recovery is real, and the market has become harder at the same time. A smaller group of companies is raising more money, faster, across fewer rounds. For anyone trying to understand which digital health startups are emerging as the next major companies, that concentration is probably the most important fact in the entire ranking.